Introduction
In the modern era of HAART, a leading cause of death in HIV-infected persons is liver disease, most often due to chronic hepatitis C virus (HCV) infection [1] . Approxi-mately one quarter of HIV-infected persons has chronic hepatitis C [2] , and HIV-HCV coinfected persons have demonstrated a more rapid progression of liver disease as compared with HCV monoinfected persons. Although the mechanism(s) are not fully known, liver disease is more severe in those with more profound CD4 þ lymphocyte depletion as compared with those with preserved peripheral blood CD4 þ lymphocyte counts [3] [4] [5] [6] [7] [8] .
HIV-induced depletion of intestinal CD4 þ lymphocytes [9] [10] [11] [12] has recently been linked to microbial translocation and HIV progression [13] . Moreover, in a cohort of HCV-infected persons at different stages of liver disease, we have shown that microbial translocation in HIV coinfected persons was strongly associated with liver disease progression [14] . In that study, we also found that HIV seroconversion among HCV-infected patients was associated with an increase in microbial translocation over time. It is, therefore, compelling to consider microbial translocation as a common mechanism that contributes to both HIV and HCV progression. Interestingly, animal models of other forms of liver disease have demonstrated a critical role of intestinal microbial translocation in promoting fibrosis [15] [16] [17] [18] [19] [20] .
Hepatic macrophages, or Kupffer cells, are responsible for clearing microbial translocation products and play a role in liver disease. Kupffer cells, however, can be infected by HIV, and this may result in their impaired ability to clear these potentially fibrogenic microbial translocation products [21] [22] [23] [24] [25] [26] [27] . In this investigation, we tested the hypotheses that Kupffer cell quantities are associated with peripheral CD4 þ lymphocyte count in HIV-HCV coinfection, and that changes in CD4 þ due to HAART are associated with corresponding alterations in Kupffer cell quantities. In addition, as in chronic viral hepatitis, fibrosis begins in the portal and periportal regions where microbial translocation products first enter the liver, we tested the hypothesis that Kupffer cells would be most abundant in these regions.
Methods
The study population derives from the HIV-HCV coinfected members of the Johns Hopkins University clinical cohort (Baltimore, Maryland) [3, 28] . Seventy-six individuals were identified who had at least two archived liver tissue samples and correlated clinical data characterizing HIV and HCV stage between January 1997 and February 2005. All participants provided written informed consent for testing through a protocol approved by the Committees on Human Research of the Johns Hopkins School of Medicine or Bloomberg School of Public Health.
Data on clinical and laboratory parameters were abstracted from the clinical and laboratory databases. Transcutaneous liver biopsies were obtained using an 18gauge needle. Liver tissue was fixed in 10% formalin and paraffin-embedded. Tissues were stained with hematoxylin and eosin (H&E) as well as trichrome. As previously described, tissues were scored by an experienced liver pathologist (M.T.) for fibrosis according to the Metavir scoring system for HCV infection and were graded for the degree of inflammation by using the Ishak modified hepatic activity index (MHAI) [29] . Hepatic fat (steatosis) was assessed as an average percentage of cells with fat (0, 1-30, 31-60, and >60%) on H&E section. The pathologist was blinded to the participants' clinical history and laboratory values. In a select group of participants who were studied longitudinally, slides obtained from the same participant were separately encoded and deidentified before handling by the pathologist. Adequacy of tissue size was determined by the pathologist, and participants with inadequate tissues were excluded from the investigation. The median length of tissues was 12 mm.
To detect Kupffer cells, tissue sections were immunostained following heat antigen retrieval with mouse monoclonal anti-CD68 antibodies (Dako, Carpinteria, California, USA), used at a 1 : 100 dilution. The DAKO EnVisionþ Peroxidase kit was used for immunostaining. Kupffer cells were identified by their strong cytoplasmic staining. Kupffer cell density (KCD) was determined as the arithmetic mean number of Kupffer cells per five high-power fields (HPFs). Portal and periportal Kupffer cells were further quantified and compared with centrilobular Kupffer cells. To detect CD68 þ /human leukocyte antigen (HLA)-DRa þ Kupffer cells, paraffinembedded tissue sections from 20 available liver blocks were selected from a subset of participants matched for MHAI score who had liver biopsies obtained at a second time point. Blocks were deparaffinized and sequentially immunostained with the anti-CD68 þ antibody followed by a rabbit polyclonal anti-HLA-DRa immunoglobulin G antibody (Santa Cruz, Santa Cruz, California, USA), both at 1 : 100 dilution. Dual sequential immunostaining was performed using the EnVision Gj2 Doublestain System (Dako). CD68 þ /HLA-DRa À , CD68 À /HLA-DRa þ , and CD68 þ /HLA-DRa þ cells were enumerated in 5-10 parenchymal HPFs and averaged.
Regional differences in KCD were characterized by quantifying all CD68 þ Kupffer cells within a 50-mm radius of selected portal and centrilobular veins. A Zeiss PALM MicroLaser system (Carl Zeiss, MicroImaging, Inc., Thornwood, New York, USA) was used to accurately determine a 50 mm radius around vessels. Although this distance extends from portal to periportal regions depending on the section, it allows for precise comparisons between portal and centrilobular Kupffer cells. Participants were selected for analysis if they had at least one suitable complete cross-section of both a well oriented portal tract and central vein. To avoid skewed results on the basis of oversampling regions of abundant inflammation, only one representative portal or centrilobular vein was used from a cluster of branching vessels. Multiple sequential sections were only used to confirm findings and not used for counting to avoid oversampling the same cells. Kupffer cell number was normalized per mm 2 to account for differences in vessel size using the adapted area of an elliptical ring, p( 1 / 2a þ 50)Â ( 1 / 2b þ 50) À p( 1 / 2a)Â( 1 / 2b), where a and b were the measured long and short axes of the vessel in mm ( Fig. 1 ). Kupffer cell counts of zero were conservatively assigned values of 0.5 per given area as the lower limit of detection. Results are reported in mm 2 .
Liver biopsies were obtained a median (range) of 1.25 (0.1-139.6) months from the assessment of CD4 þ lymphocyte count and clinical data, which were also ascertained using structured instruments before and after the initial liver biopsy, as described elsewhere [28] . KCD in all participants was approximately normally distributed. Wilcoxon rank-sum and Kruskal-Wallis tests were used to compare median KCD values across different covariates of interest. Linear regression models were used to model the association between KCD and both current and nadir CD4 þ lymphocyte count. Kupffer cell quantities per vessel were not normally distributed and were compared using Wilcoxon rank-sum tests. When log-transformed, Kupffer cell quantities per vessel yielded normally distributed data that were similarly found to be statistically significant using paired t tests.
Results
Seventy-six HIV-HCV coinfected persons with archived liver biopsies were identified. The mean age of the participants was 44.8 years at the time of the first biopsy, 59 (77.6%) were men, and 67 (88.2%) were African-American (Table 1) . Peripheral blood CD4 þ lymphocyte counts ranged from 9 to 1277/ml and serum HIV RNA ranged from undetectable to more than 400 000 copies/ ml. HAART use was reported in 57 (75%) persons. All persons had chronic HCV infection with a median RNA level of 596 000 IU/ml. HCV infection was predominantly genotype 1a (66.2%) or 1b (25.4%).
Baseline liver fibrosis stage ranged from zero to cirrhosis (Metavir 0-4). Liver inflammation ranged from MHAI zero to nine, and steatosis from zero to 60%. KCD was normally distributed over the cohort, with a median (interquartile range, IQR) of 23 cells/HPF (17.7-27.8) .
No differences were detected in the KCD distribution according to age, sex, or HCV genotype (Table 1) . Importantly, peripheral blood monocyte (Kupffer cell precursors) quantity was not associated with KCD HIV, Kupffer cells and antiretroviral therapy Balagopal et al. 2399 Age is given at the time of the first biopsy. c CD4 þ lymphocyte determinations were made within a median (range) of 1.25 (0.1-139.6) months of the first biopsy. d HIV viral RNA was determined within a median (range) of 1.50 (0.1-68.9) months of the first biopsy. e HAART was defined as use of at least two NRTIs and one protease inhibitor, or two NRTIs and one NNRTI, or two NRTIs and one NNRTI. f Metavir and MHAI staging were determined by liver biopsy by a trained pathologist (M.T.).
(P ¼ 0.25). KCD was also not associated with liver disease fibrosis stage on the concurrent or subsequent biopsy and was not associated with grade of hepatic inflammation or steatosis.
Median KCD was significantly lower in participants with lower peripheral blood CD4 þ lymphocyte counts as compared with those with higher levels (P < 0.05, by Wilcoxon rank-sum test). KCD was associated with both contemporaneous CD4 þ lymphocyte count and the lowest result recorded before histologic sampling (nadir CD4 þ count, Table 2 ).
As microbial translocation products enter the liver through the portal vein, we examined whether Kupffer cells were distributed more heavily in portal and periportal regions than centrilobular regions, as has been seen in rats [30, 31] . From the 76 archived liver biopsies, 51 cases had sufficient tissue for additional analysis. There were no significant differences in the clinical characteristics between participants with adequate liver tissue for the regional analysis and those with insufficient tissue. In total, Kupffer cells from 122 portal and 95 centrilobular regions were counted. The median (range) number of portal and periportal Kupffer cells, 328.6 (41.4-3252.8)/ mm 2 , was markedly higher than for centrilobular Kupffer cells, 90.5 (18.2-731.9)/mm 2 ( Fig. 2a and b) .
Quiescent Kupffer cells are normally immunotolerant to physiologic amounts of microbial translocation. In order to determine whether progression of AIDS was associated with Kupffer cell immune activation, 20 available liver blocks from equal number of participants with high and low MHAI scores were dually immunostained for CD68 and the activation marker HLA-DRa. Single and double-positive cells/HPF were enumerated in the hepatic parenchyma. Median KCD in this subgroup was lower than in the larger cohort (7.25 cells/HPF, range 2400 AIDS 2009, Vol 23 No 18 1.8-20 cells/HPF), and the median quantity of CD68 þ / HLA-DRa þ was 4.15 cells/HPF (range 0-11.2 cells/ HPF). HLA-DRa staining was found almost entirely on CD68 þ cells; only a median of 0.1 (range 0-2.3) cells/ HPF were CD68 À /HLA-DR þ , and this staining was confined to sinusoidal endothelial cells. There was a reciprocal trend between the number of dually stained Kupffer cells per HPF and peripheral CD4 þ lymphocyte count, but this was not statistically significant. Interestingly, the percentage of total Kupffer cells that were HLA-DR þ followed the same trend.
The relationship between CD4 þ lymphocyte count and KCD was examined further in a select subgroup of individuals who had immunosuppression (CD4 þ lymphocyte count < 350/ml) at the time of the initial biopsy, began HAART and achieved immune restoration (!2-fold increase in CD4 þ lymphocyte count), then had a second biopsy with sufficient achieved tissue. In the eight evaluable participants, biopsies were obtained at a median interval of 36.8 months (range 28.1-58.4 months). All eight participants had exposure to nucleoside reverse transcriptase inhibitors and protease inhibitors, and three participants also had exposure to nonnucleoside reverse transcriptase inhibitors. The median (IQR) increase in CD4 þ lymphocyte count was 246.5 (203-317) cells/ml and all participants had virologic suppression on HAART to less than 400 copies/ ml. (Fig. 3 ) KCD went up in all participants, from a median (IQR) of 16.6 (11-23.1) before HAART to a median (IQR) of 32 (24.6-39.2) during HAART exposure (P ¼ 0.007).
Discussion
Kupffer cells are the first line of defense against microbial translocation products that have been associated with liver HIV, Kupffer cells and antiretroviral therapy Balagopal et al. 2401 Fig. 3 . Kupffer cell density increases with immune reconstitution. Eight HIV-hepatitis C virus coinfected persons with at least two liver biopsies were selected for their initiation and response to HAART between biopsies. Biopsies were obtained at a median interval of 36.8 months apart (range 28.1-58.4 months). Response to HAART was defined as having a CD4 þ lymphocyte count at the time of the second biopsy that was at least 2Â the value at the time of the first biopsy (a). All patients had virologic suppression of serum HIV RNA (b, reference line indicates 400 copies viral RNA/ml). KCD was measured as described on the first and second biopsies (c). Symbols denote the same individuals over time and are consistent between the upper and lower panels. Because persons were preselected for increases in CD4 þ lymphocyte count on HAART, a P value was not generated for the top panels.
Ã Comparison of mean KCD on HAART with mean KCD pre-HAART using Student's t-test. y This individual, distinct in having the smallest increase in KCD during HAART, also had the highest pre-HAART CD4 þ lymphocyte count and HIV RNA. KCD, Kupffer cell density.
fibrosis. In this investigation of HIV-HCV coinfected persons, we have demonstrated that KCD is lowest in persons with the most AIDS-related immunosuppression as compared with those with preserved CD4 þ lymphocytes. In a subset of participants who were given HAART and had immune reconstitution, KCD increased along with absolute CD4 þ lymphocyte counts. These data suggest that Kupffer cell loss may contribute to liver fibrosis progression in persons with HIV-HCV coinfection and support observational studies linking HAART with slowed liver disease progression.
Immunosuppression due to HIV and other causes has been associated with HCV progression in numerous studies [3, [6] [7] [8] [32] [33] [34] [35] , and liver disease progression is slowed with the initiation of HAART [4, 36] . There have been several explanations suggested for how HIV worsens HCV progression, and we propose that Kupffer cells may also play a role. Our data showing lower Kupffer cells in persons with the lowest CD4 þ lymphocyte count, and the partial recovery of Kupffer cells with HAART and immune reconstitution suggest that the association between liver disease progression and HIV-related immunosuppression may be facilitated by Kupffer cells.
Activated Kupffer cells produce proinflammatory and profibrogenic cytokines such as tumor necrosis factoralpha and transforming growth factor-beta that in turn activate hepatic stellate cells, the proven precursors of liver fibrosis [37] . Animal models of liver injury of different causes have revealed from macrophage-depletion experiments that liver fibrosis is Kupffer cell dependent [16, 19, [38] [39] [40] . Interestingly, these experiments have shown a critical role for microbial translocation in Kupffer cell-dependent fibrosis; portal vein-derived lipopolysaccharide (LPS) and its sensing apparatus on Kupffer cells (CD14, LPS-binding protein, and Toll-like receptor 4) are required for the development of liver disease [16, 20] . Although activated Kupffer cells can promote fibrosis in the setting of liver injury, in the quiescent host, Kupffer cells are responsible for clearing microbial translocation products [41] . Activation of Kupffer cells, as measured by increased HLA-DR expression, has been found in HCV monoinfection [42] . In this study, we noted a trend suggesting that Kupffer cells are more frequently activated in persons with the lowest CD4 þ lymphocyte counts, although further work is necessary to evaluate differences between HIV-HCV coinfected and HCV monoinfected persons. Our findings provide insights into how HIV might worsen chronic viral hepatitis.
Although it is not understood how Kupffer cell function is affected by HIV infection, earlier studies [21] [22] [23] [24] [25] [26] [27] have shown that HIV preferentially infects Kupffer cells over other hepatic cells. Indeed, biopsies from HIV-infected humans and simian immunodeficiency virus (SIV)infected macaques have shown that Kupffer cells are enriched for HIV and SIV proteins, respectively [21] [22] [23] 25] . Moreover, human and macaque Kupffer cells support productive HIV infection in vitro [24, 26, 27] . As a consequence, Kupffer cell loss may be due to the direct cytotoxic effects of HIV on the Kupffer cell, or as the result of soluble viral or host factors that induce programmed cell death. HIV infection may also alter the trafficking and migration of Kupffer cells and their precursors to target sites in the liver. Although we found no association between KCD and circulating monocyte quantities, recent data from SIV-infected macaques demonstrate that although circulating monocyte levels are unchanged from baseline in animals with AIDS, high monocyte turnover correlated tightly with AIDS progression and mortality [43] .
This study also provides an explanation for the early development of periportal fibrosis in HCV infection despite clusters of HCV replication being diffusely found in the hepatic lobules. Although injury and inflammation in chronic hepatitis C infection are found throughout the lobules [44] , patterns of fibrosis in chronic viral hepatitis have long been identified as beginning in portal and periportal regions, supporting a role for intestinally derived substances in enhancing fibrosis. In this study, we found that Kupffer cells clustered next to portal veins where microbial translocation products first engage the liver, further strengthening an association between Kupffer cells, microbial translocation, and fibrosis, and providing clues to the discordant locations of HCV replication and fibrosis in chronic HCV infection. Similar portal and periportal predominance of Kupffer cells have been found in normal and diseased rats, but the implications of an intervessel Kupffer cell gradient are poorly understood [30, 31] . In our study, as the majority of study participants had low Metavir and MHAI scores, it is unlikely that portal and periportal Kupffer cell clustering is simply a reflection of nonspecific infiltrating inflammatory cells.
In this study, we did not include HCV monoinfected persons, a group that will be of importance in future studies of Kupffer cell dynamics in various mono and coinfected populations. In addition, further studies are needed to show that HIV infection of Kupffer cells is directly responsible for Kupffer cell loss. Although we did not find an association between KCD and fibrosis, our study was enriched for persons at earlier stages of liver disease, with only nine persons who had Metavir scores of at least two at baseline and only 10 persons who had significantly progressed fibrosis between the two biopsies. Of note, this cohort derived from a larger cohort of HIV-HCV coinfected patients who had limited amounts of fibrosis at early time points [3] . Also, because of the crosssectional nature of our study, the impact of past Kupffer cell activity on contemporaneous liver disorder may not be captured at the instant of biopsy. As a further limitation, we did not have more than one person independently assess KCD on all slides, although 10% of slides were scored by a second investigator with high correlation between results.
Too little is known about the relationship of KCD and their physiologic function to interpret the magnitude of differences that were observed in this study. Although the dynamic range of KCD was limited as compared with CD4 þ lymphocyte counts, the LPS-clearance capacity of Kupffer cells is thought to be quite large. Indeed, after intravenous injection of LPS into rats, most was substantially cleared by the liver, and nearly all of it was found in Kupffer cells [45] . Therefore, small differences in KCD may translate to significant changes in net clearance of microbial translocation products.
Our results suggest that Kupffer cells form a dynamic cellular population that is closely tied to peripheral CD4 þ lymphocyte counts and localizes to portals of microbial translocation. Hepatic macrophages are a filter of intestinally derived products, and dysregulated macrophage survival or trafficking in the HIV-HCV-coinfected host may be one mechanism by which liver fibrosis rapidly progresses. Further studies into the mechanisms and consequences of HIV infection of Kupffer cells as well as the physiologic effect of Kupffer cell depletion on microbial translocation will need to be explored in invitro and animal models.
